Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
PUT
CSX Corp
CSX
$95.4B
| $2.19M | ﹤0.01% |
60,400
-234,800
| -80% | -$8.4M |
|
1752
Trevi Therapeutics
TRVI
$2.56B
| $2.19M | ﹤0.01% |
174,641
-451,821
| -72% | -$5.22M |
|
|
QXO
1753
CALL
QXO Inc
QXO
$14.4B
| $2.17M | ﹤0.01% |
+112,500
| New | +$2.16M |
|
1754
PUT
Southwest Airlines
LUV
$20B
| $2.17M | ﹤0.01% |
52,500
-2,500
| -5% | -$87.3K |
|
1755
Nike
NKE
$58.6B
| $2.17M | ﹤0.01% |
34,011
+25,712
| +310% | +$1.68M |
|
1756
PUT
Wynn Resorts
WYNN
$10.2B
| $2.17M | ﹤0.01% |
18,000
-600
| -3% | -$74.2K |
|
1757
Griffon
GFF
$4.59B
| $2.16M | ﹤0.01% |
+29,390
| New | +$2.19M |
|
1758
MINISO
MNSO
$3.36B
| $2.16M | ﹤0.01% |
115,420
+82,457
| +250% | +$1.71M |
|
|
STEL
1759
DELISTED
Stellar Bancorp
STEL
| $2.16M | ﹤0.01% |
69,805
+55,831
| +400% | +$1.72M |
|
1760
PUT
F&G Annuities & Life
FG
$3.02B
| $2.16M | ﹤0.01% |
+70,000
| New | +$2.19M |
|
1761
PUT
Hims & Hers Health
HIMS
$7.41B
| $2.16M | ﹤0.01% |
66,400
-48,200
| -42% | -$2.06M |
|
1762
CALL
Riot Platforms
RIOT
$7.99B
| $2.15M | ﹤0.01% |
170,000
-465,200
| -73% | -$7.96M |
|
|
JMIA
1763
Jumia Technologies
JMIA
$853M
| $2.15M | ﹤0.01% |
172,386
+44,957
| +35% | +$520K |
|
1764
Redwire
RDW
$2.87B
| $2.15M | ﹤0.01% |
+283,282
| New | +$2.08M |
|
|
FFIC
1765
DELISTED
Flushing Financial
FFIC
| $2.15M | ﹤0.01% |
141,835
-85,709
| -38% | -$1.3M |
|
1766
Stryker
SYK
$127B
| $2.15M | ﹤0.01% |
6,105
+698
| +13% | +$254K |
|
1767
CALL
iShares MSCI Emerging Markets ETF
EEM
$31.3B
| $2.14M | ﹤0.01% |
39,200
-164,900
| -81% | -$8.97M |
|
1768
PUT
Fortinet
FTNT
$113B
| $2.14M | ﹤0.01% |
+27,000
| New | +$2.24M |
|
1769
CALL
iShares MSCI EAFE ETF
EFA
$80.4B
| $2.14M | ﹤0.01% |
22,300
+19,700
| +758% | +$1.87M |
|
1770
Liberty Media Series A
FWONA
$24.1B
| $2.14M | ﹤0.01% |
23,920
-3,124
| -12% | -$280K |
|
1771
CALL
IonQ
IONQ
$17B
| $2.13M | ﹤0.01% |
47,500
| – | – |
|
|
PSKY
1772
Paramount Skydance Corp
PSKY
$12B
| $2.13M | ﹤0.01% |
+159,039
| New | +$2.48M |
|
1773
ThredUp
TDUP
$362M
| $2.13M | ﹤0.01% |
333,125
-144,742
| -30% | -$1.17M |
|
|
BCYC
1774
CALL
Bicycle Therapeutics
BCYC
$307M
| $2.12M | ﹤0.01% |
+300,000
| New | +$2.21M |
|
1775
Brown & Brown
BRO
$24.5B
| $2.12M | ﹤0.01% |
26,601
+10,007
| +60% | +$835K |
|
Similar funds
Dmitry Balyasny's Q4 2025 Portfolio in Review
As of Q4 2025, Dmitry Balyasny held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Dmitry Balyasny withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Avidity Biosciences worth $436M.
- Dmitry Balyasny's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Dmitry Balyasny added most to Amazon in Q4 2025, an estimated $807M increase.
- Dmitry Balyasny's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Dmitry Balyasny fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Dmitry Balyasny's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Dmitry Balyasny opened 809 new positions and closed 643 in Q4 2025.
- Dmitry Balyasny's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.